These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


485 related items for PubMed ID: 29432993

  • 1. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway.
    Yang J, Ren X, Zhang L, Li Y, Cheng B, Xia J.
    Biomed Pharmacother; 2018 Apr; 100():226-232. PubMed ID: 29432993
    [Abstract] [Full Text] [Related]

  • 2. Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma.
    Wang H, Zhu L, Feng X, Zhang H, Luo Q, Chen F.
    Eur J Pharmacol; 2017 Nov 15; 815():282-289. PubMed ID: 28935563
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oridonin induces apoptosis through the mitochondrial pathway in human gastric cancer SGC-7901 cells.
    Gao S, Tan H, Zhu N, Gao H, Lv C, Gang J, Ji Y.
    Int J Oncol; 2016 Jun 15; 48(6):2453-60. PubMed ID: 27082253
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Arglabin is a plant sesquiterpene lactone that exerts potent anticancer effects on human oral squamous cancer cells via mitochondrial apoptosis and downregulation of the mTOR/PI3K/Akt signaling pathway to inhibit tumor growth in vivo.
    He W, Lai R, Lin Q, Huang Y, Wang L.
    J BUON; 2018 Jun 15; 23(6):1679-1685. PubMed ID: 30610794
    [Abstract] [Full Text] [Related]

  • 11. Furano-1,2-Naphthoquinone Inhibits Src and PI3K/Akt Signaling Pathways in Ca9-22 Human Oral Squamous Carcinoma Cells.
    Lin KL, Chien CM, Tseng CH, Chen YL, Chang LS, Lin SR.
    Integr Cancer Ther; 2014 May 15; 13(3):NP18-28. PubMed ID: 22505597
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma In Vitro and Patient-Derived Xenografts In Vivo.
    Song M, Liu X, Liu K, Zhao R, Huang H, Shi Y, Zhang M, Zhou S, Xie H, Chen H, Li Y, Zheng Y, Wu Q, Liu F, Li E, Bode AM, Dong Z, Lee MH.
    Mol Cancer Ther; 2018 Jul 15; 17(7):1540-1553. PubMed ID: 29695636
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway.
    Bao R, Shu Y, Wu X, Weng H, Ding Q, Cao Y, Li M, Mu J, Wu W, Ding Q, Tan Z, Liu T, Jiang L, Hu Y, Gu J, Liu Y.
    BMC Cancer; 2014 Mar 21; 14():217. PubMed ID: 24655726
    [Abstract] [Full Text] [Related]

  • 19. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
    Huang KJ, Kuo CH, Chen SH, Lin CY, Lee YR.
    J Cell Mol Med; 2018 Mar 21; 22(3):1894-1908. PubMed ID: 29363886
    [Abstract] [Full Text] [Related]

  • 20. Oridonin induces apoptosis via PI3K/Akt pathway in cervical carcinoma HeLa cell line.
    Hu HZ, Yang YB, Xu XD, Shen HW, Shu YM, Ren Z, Li XM, Shen HM, Zeng HT.
    Acta Pharmacol Sin; 2007 Nov 21; 28(11):1819-26. PubMed ID: 17959034
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.